STAA's logo.
Ticker Symbol: STAA

Staar Surgical Co.

$115.79 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000718937

Company Profile

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3851
Address: 25651 Atlantic Ocean Drive
Website: www.staar.com
CEO: Caren Mason
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $39.35
Change: -$0.26 ( -0.66%)
Days Range: $38.67 - $39.86
Beta: 1.77
52wk. High: $81.81
52wk. Low: $37.01
Ytd. Change -19.05%
50 Day Moving Average: $41.32
200 Day Moving Average: $52.26
Shares Outstanding: 48499892

Valuation

Market Cap: 190.8B
PE Ratio: 78.28
EPS (TTM): 0.5027

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A